Patients paralyzed due to spinal cord injuries may one day achieve substantial or even complete recovery following stem cell and exosome therapy, according to clinical research. Though these treatments are not yet approved by the U.S. Food and Drug Administration (FDA), studies have shown that these two novel regenerative medicine treatments offer hope for those suffering from previously incurable conditions such as traumatic paralysis.
Stem cells, which have the unique ability to self-renew and differentiate into various cell types, can be directed to develop into specific types of cells, thus helping to regenerate and repair tissues damaged or affected by disease.
